Vai al contenuto
Cellule endoteliali della vena safena umana (HSVEC)
Tessuto
Saphenous vein
Malattia
Normal saphenous vein endothelium (primary cells; non-tumorigenic)
Sito metastatico
Not applicable (normal, non-tumorigenic primary cell)
Sinonimi
HSaVEC, HSVEC, Human saphenous vein endothelial cells, provitro 1210121

Documenti

Cellule endoteliali della vena safena umana (HSVEC)

Primary cell · Codice prodotto 300699

Venous endothelium for bypass graft research

€1,220.00IVA e spese di spedizione escluse

Personalizzazione / Suggerimenti

Su ordinazione
1

01Informazioni generali

Descrizione

Primary Human Saphenous Vein Endothelial Cells (HSaVEC) are isolated from the saphenous vein and offer a venous endothelial model alongside HUVEC. They are used in research on atherosclerosis, leukocyte adhesion and the endothelial failure of coronary bypass vein grafts.

HSaVEC show the typical cobblestone morphology and express CD31 and VE-cadherin. As cells from adult vessels, they differ from fetal HUVEC: they are more sensitive to oxidized LDL, respond less strongly to cytokines and can present antigen to T cells, making them a closer model of adult venous endothelium.

Tessuto
Saphenous vein
Malattia
Normal saphenous vein endothelium (primary cells; non-tumorigenic)
Sito metastatico
Not applicable (normal, non-tumorigenic primary cell)
Applicazioni
Adult endothelial model: ox-LDL, leukocyte adhesion, antigen presentation and tumor cell adhesion; Endothelial dysfunction in coronary bypass patients, screening of interventions; Mechanobiology: shear stress and arterial-level stretch in vein graft arterialization; Oxidative stress and mitophagy in vein graft failure; Insulin and IGF-1 receptor signaling in type 2 diabetes; Biomaterials: bioactive wound dressings for chronic wounds
Sinonimi
  • HSaVEC
  • HSVEC
  • Human saphenous vein endothelial cells
  • provitro 1210121

02Donatore

Età dei donatori
Lot-specific (see CoA)
Etnia
Lot-specific (see CoA)

03Classificazione

Organismo
Umano
Sesso
Specifico per lotto
Proprietà di crescita
Aderente
Presenza di OGM
Senza OGM
Dettagli sullo stato degli OGM
No genetic modification; primary human endothelial cells isolated from saphenous vein tissue. Not transformed or immortalized.
Livello di biosicurezza
1

04Caratteristiche

Morfologia
Cobblestone (endothelial)
Tipo di cellula
Primary endothelial cells
Tumorigenico
No
Tempo di raddoppio
approx. 24 hours (under optimal EGM-2/EBM-2 conditions, Marelli-Berg et al. 2004)

05Manipolazione e coltura

Terreno di coltura
Endothelial Cell Growth Medium
Atmosfera di incubazione

37°C, 5% CO2, saturated humidity.

Integratori
EGM-2-MV BulletKit supplements: hEGF, VEGF, hFGF-B, IGF-1, hydrocortisone, ascorbic acid, heparin, and 5% FBS (pre-formulated in EGM-2; no additional serum needed). Gelatin-coat culture vessels before seeding.
Reagente di dissociazione
Subculture reagents as recommended on the certificate of analysis
Rivestimento del pallone
0.1–0.2% gelatin coating required (incubate gelatin solution 30 min at 37°C, aspirate excess before seeding)
Subcoltura

Subculture the cells at about 75 % confluence. Denser cultures undergo irreversible contact inhibition and stop proliferating. Use the subculture reagents recommended on the certificate of analysis.

Rapporto di frazionamento
1 to 3
Densità di semina
More than 6,000 cells/cm²
Rinnovo dei fluidi
24 hours after seeding, then every 48 to 72 hours
Recupero post-scongelamento

Post-thaw viability ≥ 70 % viable cells. More than 80 % confluence within the expected recovery period.

Scongelamento e coltura
  1. Thaw the cryovial quickly in a 37 °C water bath, swirling gently. Just before the last ice has melted, move the vial to a laminar flow hood and decontaminate its outer surface.

  2. Transfer the cell suspension into a 15 ml centrifuge tube, add 10 ml of Endothelial Cell Growth Medium and centrifuge at 250 × g for 5 minutes.

  3. Remove the supernatant and resuspend the cell pellet in 10 ml of Endothelial Cell Growth Medium. Check cell number and viability.

  4. Divide the suspension between two 25 cm² culture flasks (5 ml each). Using two flasks reduces the risk of losing all cells if a passage fails.

  5. Incubate at 37 °C, 5 % CO₂ and saturated humidity, with the screw caps opened by half a turn for gas exchange.

  6. Change the medium after 24 hours to remove unattached cells, then every 48 to 72 hours, using pre-warmed medium only.

  7. Subculture the cells at about 75 % confluence. Denser cultures undergo irreversible contact inhibition and stop proliferating. Use the subculture reagents recommended on the certificate of analysis.

  8. Recommended seeding density: more than 6,000 cells/cm².

06Controllo di qualità e crioconservazione

Sterilità

Mycoplasma contamination is excluded by PCR.

To ensure there is no bacterial, fungal or yeast contamination, cultures are subjected to visual inspection.

Terreno di coltura congelato
As a cryopreservation medium, we use complete growth medium + 10% DMSO for adequate post-thaw viability.
Condizioni di conservazione

For long-term preservation, store vials in liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable for up to one week only.

Condizioni di spedizione

Cryopreserved primary cells are shipped on dry ice. On receipt, check the cryovial for damage and transfer it without delay to appropriate storage.

07Espressione e suscettibilità

Antigeni di superficie
CD31 (PECAM-1); VE-cadherin (CD144); von Willebrand factor (vWF); eNOS; HLA-DR (inducible); ICAM-1 (inducible); VCAM-1 (inducible); E-selectin (inducible); UEA-I lectin binding
Recettori espressi
VEGFR2 (KDR); VEGFR1; TIE-2; EGFR (low)

08Identificatori

Riferimento bibliografico
Human saphenous vein endothelial cells (HSVEC) (Cytion catalog number 300699)
Codice fiscale NCBI
9606
Cellosaurus
Not assigned